4.3 Review

Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence

Journal

ONCOTARGET
Volume 7, Issue 32, Pages 52517-52529

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.9593

Keywords

cancer chemoprevention; phytochemicals; resveratrol; curcumin; antioxidants

Funding

  1. Ministry of Education, Culture, Sports and Technology of Japan
  2. Research on Allergic Disease and Immunology in Health and Labor Science Grant from the Ministry of Health, Labour and Welfare of Japan [H26-106]
  3. SENSHIN Medical Research Foundation (Osaka, Japan)
  4. Aichi Cancer Research Foundation (Nagoya, Japan)
  5. 24th General Assembly of the Japanese Association of Medical Sciences (Nagoya, Japan)
  6. Grants-in-Aid for Scientific Research [15K09513] Funding Source: KAKEN

Ask authors/readers for more resources

Cancer chemoprevention involves the use of different natural or biologic agents to inhibit or reverse tumor growth. Epidemiological and pre-clinical data suggest that various natural phytochemicals and dietary compounds possess chemopreventive properties, and in-vitro and animal studies support that these compounds may modulate signaling pathways involved in cell proliferation and apoptosis in transformed cells, enhance the host immune system and sensitize malignant cells to cytotoxic agents. Despite promising results from experimental studies, only a limited number of these compounds have been tested in clinical trials and have shown variable results. In this review, we summarize the data regarding select phytochemicals including curcumin, resveratrol, lycopene, folates and tea polyphenols with emphasis on the clinical evidence supporting the efficacy of these compounds in high-risk populations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available